As a case in point, tumor cells often upregulate the immune checkpoint protein Programmed Death-Ligand 1 (PD-L1) (11), either in response to inflammatory cytokines, such as Interferon gamma (IFNγ), or through constitutive oncogenic signaling (10). Here, IFNG is linked to neoplasm.